Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen AsfiledCriticalSymphogen As
Publication of AR121839A1publicationCriticalpatent/AR121839A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Esta invención se refiere a anticuerpos anti-FLT3 y a métodos de uso de los mismos para potenciar la inmunidad en un paciente que lo necesita y para tratar el cáncer.This invention relates to anti-FLT3 antibodies and methods of using them to enhance immunity in a patient in need thereof and to treat cancer.
ARP210100982A2021-04-142021-04-14
ANTI-FLT3 ANTIBODIES AND COMPOSITIONS
AR121839A1
(en)